Get the Stockscreener App
11.63
1.61%
-0.19
Elanco Animal Health Inc stock is traded at $11.63, with a volume of 8.46M.
It is down -1.61% in the last 24 hours and down -13.47% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$11.82
Open:
$11.73
24h Volume:
8.46M
Relative Volume:
1.74
Market Cap:
$5.75B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
-58.15
EPS:
-0.2
Net Cash Flow:
$372.00M
1W Performance:
-3.88%
1M Performance:
-13.47%
6M Performance:
-36.10%
1Y Performance:
-16.99%
1-Day Range:
$11.63
$12.19
1-Week Range:
$11.50
$12.47
52-Week Range:
$11.40
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
11.63 | 5.75B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Stifel Financial Corp Has $1.65 Million Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Canine Atopic Dermatitis Market Projected for Significant Growth (2024-2031) | Zoetis, Elanco, Virbac. - openPR
Elanco Confirms Date and Conference Call for Third Quarter 2024 Financial Results Announcement - Kilgore News Herald
Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - PR Newswire
Elanco Acquires Speke Contract Manufacturing Facility, Securing Key Supply Chain - The Eastern Progress Online
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Bought by Geode Capital Management LLC - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Receives $16.75 Consensus Target Price from Analysts - MarketBeat
Elanco Animal Health's SWOT analysis: stock outlook amid product launches, challenges - Investing.com Canada
2024 veterinary news in review: #17 - DVM 360
Animal Healthcare Market Next Big Thing | Big Giants Elanco, Bayer, Phibro Animal Health - openPR
Elanco Animal Health Incorporated's (NYSE:ELAN) Business And Shares Still Trailing The Industry - Simply Wall St
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 6, 2024 to Discuss Your RightsELAN - The Eastern Progress Online
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - The Eastern Progress Online
Wellington Management Group LLP Purchases 646,522 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN Class Action News: Robbins LLP Reminds Investors of the Quickly Approaching Lead Plaintiff Deadline in the Elanco Animal Health Incorporated Class Action - The Eastern Progress Online
UBS Initiates Coverage of Elanco Animal Health (ELAN) with Buy Recommendation - MSN
NYSE: ELAN Lawsuit Alert: Investors who lost money with Elanco Animal Health Incorporated shares should contact the Shareholders Foundation - PR Newswire
Elanco Animal Health (NYSE:ELAN) Earns Buy Rating from Analysts at UBS Group - MarketBeat
Veterinary Oncology Market Generated Opportunities, Future - openPR
Quantinno Capital Management LP Acquires 100,183 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Fmr LLC - MarketBeat
Point72 Asset Management L.P. Purchases Shares of 1,341,582 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ELAN Deadline Today: Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - Business Wire
Class Action Filed Against Elanco Animal Health Incorporated (ELAN)December 6, 2024 Deadline to JoinContact Levi & Korsinsky - Morningstar
Veterinary Medicine Market Expected to Surge by 2031 Elanco - openPR
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 44,370 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN Deadline: ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
Shareholders that lost money on Elanco Animal Health Incorporated(ELAN) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
Edgestream Partners L.P. Acquires Shares of 62,958 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Purchased by BNP Paribas Financial Markets - MarketBeat
ELAN Investors Have Opportunity to Lead Elanco Animal Health Inc - GuruFocus.com
Elanco Animal Health Inc (ELAN) Shares Gap Down to $12.74 on Dec 3 - GuruFocus.com
What is Leerink Partnrs' Forecast for ELAN FY2024 Earnings? - MarketBeat
ELAN CLASS ACTION: A Securities Fraud Class Action Lawsuit - GlobeNewswire
Top 3 Health Care Stocks That Could Blast Off In December - Benzinga
Director Garcia Art A was granted 18,169 shares, increasing direct ownership by 29% to 80,964 units (SEC Form 4) - Quantisnow
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):